Description
A non-enzymatic oxidation product of EPA; increased in the plasma and heart, as well as in the supernatant of cultured peritoneal macrophages isolated from fat-1 transgenic mice; reduces increases in cardiac fibrosis and the expression of Nppa, Col1a1, Tgfb1, Cx3cl1, and Adgre1 induced by transverse aortic constriction in a mouse model of cardiac hypertrophy at 1 and 5 µg
Formal name: (±)-18-hydroxy-5Z,8Z,11Z,14Z,16E-eicosapentaenoic acid
Synonyms:
Molecular weight: 318.5
CAS: 141110-17-0
Purity: ≥97%
Formulation: A solution in ethanol
Product Type|Biochemicals|Lipids|Hydroxy/Hydroperoxy/ Epoxy/Oxo Eicosanoids||Research Area|Cardiovascular System|Heart|Myocardial Hypertrophy||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Lipid Biochemistry|Reactive O2/N2 Pathways||Research Area|Oxidative Stress & Reactive Species|Lipid Peroxidation